Surgical Approaches for Implanting Xen Gel Stent without Conjunctival Dissection.
Clin Ophthalmol
; 14: 2361-2371, 2020.
Article
em En
| MEDLINE
| ID: mdl-32903875
ABSTRACT
The XEN Gel Stent (Allergan Inc., an Abbvie company) is an implant that lowers intraocular pressure by creating a filtration pathway from the anterior chamber to the subconjunctival space, using the same pathway as trabeculectomy. While the primary method for implantation is via ab interno approach, it is also possible to implant the device ab externo. This technique paper details the surgical steps for closed conjunctival implantation of the Gel Stent and provides surgical pearls for enhancing outcomes.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article